Directions: For each of the scenarios below, answer the questions below using clinical practice guideline where applicable. Explain the problem and explain how you would address the problem. If prescribing a new drug, write out a complete medication order just as you would if you were completing a prescription. Use at least 3 sources for each scenario and cite sources using APA format.
- Sara is a 45-year-old female presenting for her annual exam. Her blood pressure today is 160/90 HR 84 RR 16. Her height is 64 inches and her weight is 195. Her last visit to the clinic 3 months ago shows a BP of 156/92. She is currently taking ibuprofen 600 mg tid for back pain. She has no known allergies. What is the goal for her blood pressure? What medication would you prescribe to treat her blood pressure? What education would you prescribe?
Based on Sara’s current blood pressure readings of 160/90 mmHg, she is classified as having stage 2 hypertension according to the American Heart Association’s guidelines. The goal for her blood pressure would be to reduce it to below 130/80 mmHg, as recommended for adults with hypertension.
Considering Sara’s medical history and current medication regimen, it’s important to select an antihypertensive medication that will effectively lower her blood pressure without interacting negatively with her ibuprofen. Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), can potentially decrease the effectiveness of certain blood pressure medications, particularly those that belong to the class of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs).
Given Sara’s stage 2 hypertension and the need to avoid drug interactions with ibuprofen, an appropriate choice for her blood pressure medication could be a calcium channel blocker (CCB) such as amlodipine. Amlodipine is effective in lowering blood pressure and is less likely to interact with ibuprofen compared to ACE inhibitors or ARBs.
The education prescribed for Sara would include lifestyle modifications to help manage her blood pressure. This could involve dietary changes to reduce sodium intake, increase potassium-rich foods, and adopt the DASH (Dietary Approaches to Stop Hypertension) diet. Additionally, encouraging regular physical activity, weight management, stress reduction techniques, and smoking cessation (if applicable) would be important components of her education plan. Sara should also be advised to discuss any concerns or side effects of her medications with her healthcare provider and to adhere to her prescribed treatment regimen consistently.
In summary:
– Goal for blood pressure: <130/80 mmHg
– Medication: Amlodipine
– Education: Lifestyle modifications including dietary changes, regular physical activity, weight management, stress reduction techniques, smoking cessation (if applicable), and medication adherence.
- Monty is a 52-year-old male following up on his labs that were drawn last week. He smokes 1 pack per day. He is currently on Lisinopril 20 mg po daily. He is allergic to penicillin. Fasting lipid profile shows total cholesterol 266, LDL cholesterol 180, HDL cholesterol 40, and Triglycerides 185. What treatment plan would you implement for Monty’s lipid profile? What is the goal Total Cholesterol (TC), HDL-C, and LDL-C level for Monty? How would you monitor the effectiveness of your treatment plan? How many risk factors for coronary artery disease does this patient have? Identify them specifically.
Based on Monty’s lipid profile results, he has dyslipidemia with elevated total cholesterol (TC), elevated low-density lipoprotein cholesterol (LDL-C), low high-density lipoprotein cholesterol (HDL-C), and elevated triglycerides. Given his age, smoking history, and lipid profile, Monty is at increased risk for coronary artery disease (CAD).
**Treatment Plan:**
- **Lifestyle Modifications:** Encourage Monty to make lifestyle changes to improve his lipid profile, including smoking cessation, adopting a heart-healthy diet low in saturated fats and cholesterol, increasing physical activity, and achieving or maintaining a healthy weight.
- **Medication:** Considering Monty’s elevated LDL-C levels and his allergy to penicillin, a statin medication would be appropriate for him to help lower his LDL-C levels. A moderate-intensity statin such as atorvastatin 20-40 mg daily would be a suitable choice to start with.
- **Monitoring:** Monty’s lipid profile should be monitored regularly to assess the effectiveness of the treatment plan. Follow-up lipid panels should be conducted after initiating statin therapy and periodically thereafter to evaluate lipid levels and adjust treatment as needed.
- **Risk Factor Management:** In addition to lipid management, other cardiovascular risk factors should be addressed, including blood pressure control, diabetes management (if present), and lifestyle modifications such as smoking cessation and regular exercise.
**Goal Lipid Levels:**
– **Total Cholesterol (TC):** <200 mg/dL
– **LDL Cholesterol (LDL-C):** <100 mg/dL (or <70 mg/dL for high-risk individuals)
– **HDL Cholesterol (HDL-C):** >40 mg/dL for men
– **Triglycerides:** <150 mg/dL
**Monitoring Effectiveness:**
The effectiveness of the treatment plan can be monitored by regularly checking Monty’s lipid profile to assess changes in TC, LDL-C, HDL-C, and triglyceride levels. Additionally, evaluating any improvements in other cardiovascular risk factors such as blood pressure and smoking status would indicate the effectiveness of lifestyle modifications.
**Risk Factors for CAD:**
- **Age:** Monty is 52 years old, which increases his risk for CAD.
- **Smoking:** Monty smokes 1 pack per day, which is a significant risk factor for CAD.
- **Elevated LDL-C:** Monty’s LDL-C level of 180 mg/dL is elevated, further increasing his risk for CAD.
- **Low HDL-C:** Monty’s HDL-C level of 40 mg/dL is below the recommended levels, contributing to his risk for CAD.
- **Dyslipidemia:** Monty’s lipid profile shows dyslipidemia with elevated TC, LDL-C, and triglycerides, which is a risk factor for CAD.
In conclusion, Monty requires a comprehensive treatment plan that includes lifestyle modifications and pharmacotherapy to manage his dyslipidemia and reduce his risk for CAD. Regular monitoring of his lipid profile and other cardiovascular risk factors is essential to assess the effectiveness of the treatment plan and make necessary adjustments to optimize his cardiovascular health.
ORDER A PLAGIARISM-FREE PAPER HERE
An Original Human-Crafted Assignment
- Beatrice is a 17-year-old female diagnosed with mild persistent asthma since age 7. During her visit today, she reports having to use her albuterol MDI 3 to 4 days per week over the past 2 months. Over the past week she has been using albuterol at least once per day. She reports being awakened by a cough three nights during the last month. She is becoming more short of breath with exercise. She also has a fluticasone MDI, which she uses “most days of the week.” Her current medications include: Flovent HFA 44 mcg, two puffs BID, Proventil HFA two puffs Q 4–6 H PRN shortness of breath, Yaz one PO daily, Propranolol 80 mg PO BID. What treatment plan would you implement for this patient? What medication changes would you make? How would you monitor the effectiveness of this plan?
Based on Beatrice’s symptoms and medication use, it appears that her asthma is not well-controlled despite her current treatment regimen. Here is a proposed treatment plan:
Assessment of Asthma Control:**
Beatrice’s symptoms suggest poor asthma control, including increased frequency of albuterol use, nighttime awakenings due to coughing, and worsening shortness of breath with exercise. Therefore, the treatment plan will focus on achieving better asthma control to reduce symptoms and prevent exacerbations.
Medication Changes:**
– **Increase Flovent Dosage:** Given Beatrice’s symptoms, the dose of her inhaled corticosteroid (ICS), Flovent HFA (fluticasone), should be increased to improve asthma control. A higher dose may be necessary to achieve better symptom control.
– **Addition of Long-Acting Beta Agonist (LABA):**
Since Beatrice’s asthma is not well-controlled despite using an ICS, adding a long-acting beta agonist (LABA) to her treatment regimen may be beneficial. LABAs, such as salmeterol or formoterol, provide additional bronchodilation and help control asthma symptoms when used in combination with an ICS.
– **Review Propranolol Use:**
Propranolol, a non-selective beta-blocker, may worsen asthma symptoms and should be used with caution in individuals with asthma. Depending on the indication for propranolol use, consideration may be given to discontinuing or substituting it with a beta-blocker that is less likely to exacerbate asthma.
Education and Inhaler Technique:**
Ensure Beatrice understands how to use her inhalers correctly, including proper inhaler technique and adherence to prescribed medication schedules. Education should also include asthma triggers, symptom recognition, and when to seek medical attention for worsening symptoms or exacerbations.
**Monitoring Effectiveness:**
– **Symptom Assessment:** Monitor Beatrice’s asthma symptoms regularly, including daytime and nighttime symptoms, frequency of albuterol use, and exercise tolerance.
– **Peak Flow Monitoring:** Consider implementing peak flow monitoring to assess Beatrice’s lung function and track changes over time. Regular peak flow measurements can help evaluate asthma control and guide treatment adjustments.
– **Follow-Up Visits:** Schedule regular follow-up visits with Beatrice to assess her response to the treatment plan, adjust medications as needed, and provide ongoing asthma education and support.
In summary, the proposed treatment plan for Beatrice involves optimizing her asthma medications by increasing the dose of her ICS, adding a LABA, and potentially reviewing her use of propranolol. Monitoring her asthma symptoms, lung function, and medication adherence will be essential to evaluate the effectiveness of the treatment plan and make any necessary adjustments to achieve better asthma control and improve Beatrice’s quality of life.
- Daute is a 56-year-old man seeking evaluation for increasing shortness of breath. He noticed difficulty catching his breath about 3 years ago. Physical activity increases his symptoms. He avoids activity as much as possible to prevent any SOB. His previous physician had placed him on salmeterol/fluticasone (Advair Diskus) one inhalation twice daily 2 years ago. He thinks his physician initiated the medication for the shortness of breath, but he is not entirely sure. He did not refill the prescription and has not been taking it. Pertinent history – Chronic bronchitis X 8 years with one exacerbation in last 12 months of treatment with oral antibiotics. He has a 40-pack-year smoking history. What treatment plan would you implement for this patient? What medication(s) would you prescribe? How would you monitor the effectiveness of this plan?
Based on Daute’s symptoms and medical history, it appears that he is experiencing worsening shortness of breath due to his chronic bronchitis and possible chronic obstructive pulmonary disease (COPD). Here is a proposed treatment plan:
**Assessment of Respiratory Symptoms:**
Daute’s increasing shortness of breath with physical activity suggests worsening respiratory function. It’s essential to evaluate his lung function and assess the severity of his airflow limitation to guide treatment decisions.
**Medication Management:**
– **Restart Salmeterol/Fluticasone (Advair Diskus):** Given Daute’s history of chronic bronchitis and exacerbations, restarting his previous medication, salmeterol/fluticasone (Advair Diskus), would be appropriate. This combination inhaler provides both a long-acting beta agonist (LABA) and an inhaled corticosteroid (ICS), which can help improve lung function, reduce inflammation, and alleviate symptoms in patients with COPD.
– **Consider Adding Short-Acting Bronchodilator (SABA):** In addition to Advair Diskus, Daute may benefit from a short-acting bronchodilator, such as albuterol, for quick relief of acute symptoms of breathlessness. This rescue inhaler can be used as needed to provide immediate bronchodilation during exacerbations or episodes of increased shortness of breath.
– **Smoking Cessation Counseling:** Given Daute’s significant smoking history, smoking cessation counseling and support should be offered to help him quit smoking and slow the progression of his respiratory disease.
**Pulmonary Function Testing (PFT):**
Perform spirometry to assess Daute’s lung function, including forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). Repeat PFTs at regular intervals to monitor changes in lung function and evaluate the effectiveness of treatment.
**Symptom Assessment:**
Monitor Daute’s respiratory symptoms, including shortness of breath, cough, and sputum production, regularly to assess the effectiveness of his medication regimen. Encourage him to keep a symptom diary to track any changes or exacerbations.
**Follow-Up Visits:**
Schedule regular follow-up appointments with Daute to review his symptoms, medication adherence, and lung function test results. Adjust his treatment plan as needed based on his clinical response and any changes in his respiratory status.
In summary,
the proposed treatment plan for Daute involves restarting his previous medication regimen with salmeterol/fluticasone (Advair Diskus), considering the addition of a short-acting bronchodilator for acute symptom relief, and providing smoking cessation counseling. Monitoring his symptoms and lung function over time will be essential to assess the effectiveness of the treatment plan and optimize his respiratory health.
For each of the scenarios below, answer the questions below using clinical practice guidelines where applicable
"Place your order now for a similar assignment and have exceptional work written by our team of experts, guaranteeing you "A" results."
